| Meeting code | WIPO/GC/INN/GE/14 |
| Date and venue | December 5, 2014 (Geneva, Switzerland) Onsite |
| Previous / future meetings | WIPO/GC/SEM/GE/14 >> WIPO/GC/INN/GE/14 >> WIPO/GC/TD/GE/15 |
| Topic(s) | Workshops and Seminars |
Global Challenges Seminar - "Innovation and Access to Medicines: A Case Study for HIV/AIDS and Hepatitis C"
Meeting documents
| Code | Title(s) | File(s) | |
|---|---|---|---|
| WIPO/GC/INN/GE/14/INF/1 PROV. | English | Provisional Program |   |
Other related documents
| Title(s) | File(s) | ||
|---|---|---|---|
| WIPO/GC/INN/GE/14/T1 | English | Innovation and Access to Medicines: Case Study for HIV/AIDS and Hepatitis C: Trends in voluntary licensing - Peter Beyer, WHO |  |
| WIPO/GC/INN/GE/14/T2 | English | Innovation and Access to Medicines: A Case Study for HIV/AIDS and Hepatitis C - Gregg Alton, Gilead Sciences Inc. | |
| WIPO/GC/INN/GE/14/T3 | English | Innovation and Access to Medicines: A Case Study for HIV/AIDS and Hepatitis C - Manica Balasegaram, Médecins Sans Frontières | |
| WIPO/GC/INN/GE/14/VIDEO | English | Video of the Seminar |  |